Abeona Therapeutics Inc. (ABEO) stock
ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3039% below fair value
$2.42+0.13 (+5.68%)
Close on Nov 13, 2026Market cap $138.39MP/E –Yield –
Abeona Therapeutics cash
Cash and short-term investments held at the end of each period.
Abeona Therapeutics's cash was $134.94M at Sep 30, 2026. For fiscal 2025 it was $191.40M, up 95.1% from the year before. Over ten years it grew 16.9% a year on average. The highest annual figure on record is $191.40M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $191.40M | +95.1% |
| FY2024 | Dec 31, 2024 | $98.10M | +86.5% |
| FY2023 | Dec 31, 2023 | $52.60M | +0.2% |
| FY2022 | Dec 31, 2022 | $52.50M | +3.1% |
| FY2021 | Dec 31, 2021 | $50.90M | -46.4% |
| FY2020 | Dec 31, 2020 | $95.00M | -26.5% |
| FY2019 | Dec 31, 2019 | $129.26M | +52.1% |
| FY2018 | Dec 31, 2018 | $85.00M | -38.3% |
| FY2017 | Dec 31, 2017 | $137.75M | +99.2% |
| FY2016 | Dec 31, 2016 | $69.14M | +72.3% |
| FY2015 | Dec 31, 2015 | $40.14M | +248.4% |
| FY2014 | Dec 31, 2014 | $11.52M | +2617.0% |
| FY2013 | Dec 31, 2013 | $424.00K | +7.1% |
| FY2012 | Dec 31, 2012 | $396.00K | -83.9% |
| FY2011 | Dec 31, 2011 | $2.46M | -65.0% |
| FY2010 | Dec 31, 2010 | $7.03M | +1058.6% |
| FY2009 | Dec 31, 2009 | $607.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $134.94M | -34.8% |
| Q2 FY2026 | Jun 30, 2026 | $146.83M | -34.9% |
| Q1 FY2026 | Mar 31, 2026 | $168.27M | +99.1% |
| Q4 FY2025 | Dec 31, 2025 | $191.40M | +95.1% |
| Q3 FY2025 | Sep 30, 2025 | $207.12M | +88.3% |
| Q2 FY2025 | Jun 30, 2025 | $225.52M | +83.3% |
| Q1 FY2025 | Mar 31, 2025 | $84.50M | +34.8% |
| Q4 FY2024 | Dec 31, 2024 | $98.10M | +86.5% |
| Q3 FY2024 | Sep 30, 2024 | $110.00M | +103.3% |
| Q2 FY2024 | Jun 30, 2024 | $123.00M | +231.5% |
| Q1 FY2024 | Mar 31, 2024 | $62.70M | +54.1% |
| Q4 FY2023 | Dec 31, 2023 | $52.60M | +0.2% |
| Q3 FY2023 | Sep 30, 2023 | $54.10M | +130.2% |
| Q2 FY2023 | Jun 30, 2023 | $37.10M | +42.7% |
| Q1 FY2023 | Mar 31, 2023 | $40.70M | +9.4% |
| Q4 FY2022 | Dec 31, 2022 | $52.50M | +3.1% |
| Q3 FY2022 | Sep 30, 2022 | $23.50M | -64.9% |
| Q2 FY2022 | Jun 30, 2022 | $26.00M | -66.5% |
| Q1 FY2022 | Mar 31, 2022 | $37.20M | -57.1% |
| Q4 FY2021 | Dec 31, 2021 | $50.90M | -46.4% |
| Q3 FY2021 | Sep 30, 2021 | $67.00M | -35.5% |
| Q2 FY2021 | Jun 30, 2021 | $77.60M | -28.1% |
| Q1 FY2021 | Mar 31, 2021 | $86.80M | -25.2% |
| Q4 FY2020 | Dec 31, 2020 | $95.00M | -26.5% |
| Q3 FY2020 | Sep 30, 2020 | $103.90M | +116.9% |
| Q2 FY2020 | Jun 30, 2020 | $107.90M | +72.6% |
| Q1 FY2020 | Mar 31, 2020 | $116.00M | +69.8% |
| Q4 FY2019 | Dec 31, 2019 | $129.26M | +52.1% |
| Q3 FY2019 | Sep 30, 2019 | $47.90M | -57.3% |
| Q2 FY2019 | Jun 30, 2019 | $62.50M | -47.8% |
| Q1 FY2019 | Mar 31, 2019 | $68.30M | -48.3% |
| Q4 FY2018 | Dec 31, 2018 | $85.00M | -38.3% |
| Q3 FY2018 | Sep 30, 2018 | $112.22M | +98.5% |
| Q2 FY2018 | Jun 30, 2018 | $119.84M | +105.5% |
| Q1 FY2018 | Mar 31, 2018 | $132.00M | +108.8% |
| Q4 FY2017 | Dec 31, 2017 | $137.75M | +99.2% |
| Q3 FY2017 | Sep 30, 2017 | $56.52M | – |
| Q2 FY2017 | Jun 30, 2017 | $58.30M | – |
| Q1 FY2017 | Mar 31, 2017 | $63.21M | – |
| Q4 FY2016 | Dec 31, 2016 | $69.14M | – |
See a number that looks wrong?